TY - JOUR
T1 - X-ray crystallographic determination of the structure of the influenza C virus haemagglutinin-esterase-fusion glycoprotein
AU - Zhang, Xiaodong
AU - Rosenthal, Peter B.
AU - Formanowski, Frank
AU - Fitz, Wolfgang
AU - Wong, Chi Huey
AU - Meier-Ewert, H.
AU - Skehel, John J.
AU - Wiley, Don C.
PY - 1999/5
Y1 - 1999/5
N2 - The structure of the haemagglutinin-esterase-fusion (HEF) glycoprotein from influenza C virus has been determined to 3.2 Å resolution by X-ray crystallography. A synthetic mercury-containing esterase inhibitor and receptor analogue, 9-acetamidosialic acid α-thiomethylmercuryglycoside, was designed as the single isomorphous heavy-atom derivative. The asymmetric unit of one crystal form (form I; P4322, a = b = 155.4, c = 414.4 Å) contained an HEF trimer. Six mercury sites identifying the three haemagglutination and three esterase sites were located by difference Patterson map analysis of a 6.5 Å. resolution derivative data set. These positions defined the molecular threefold-symmetry axis of the HEF trimer. A molecular envelope was defined by averaging a 7.0 Å resolution electron-density map, phased by single isomorphous replacement (SIR), about the non-crystallographic threefold-symmetry axis. Iterative non-crystallographic symmetry averaging in real space, solvent flattening and histogram matching were used to extend the phases to 3.5 Å resolution. Molecular replacement of the model into a second crystal form (form II; P43212, a = b = 217.4, c = 421.4 Å) containing two HEF trimers per asymmetric unit permitted iterative ninefold averaging of the electron density. The 3.5 Å electron-density map allowed an unambiguous tracing of the polypeptide chain and identification of N-linked carbohydrates. The model has been refined by least squares to 3.2 Å resolution (R(free) = 26.7%).
AB - The structure of the haemagglutinin-esterase-fusion (HEF) glycoprotein from influenza C virus has been determined to 3.2 Å resolution by X-ray crystallography. A synthetic mercury-containing esterase inhibitor and receptor analogue, 9-acetamidosialic acid α-thiomethylmercuryglycoside, was designed as the single isomorphous heavy-atom derivative. The asymmetric unit of one crystal form (form I; P4322, a = b = 155.4, c = 414.4 Å) contained an HEF trimer. Six mercury sites identifying the three haemagglutination and three esterase sites were located by difference Patterson map analysis of a 6.5 Å. resolution derivative data set. These positions defined the molecular threefold-symmetry axis of the HEF trimer. A molecular envelope was defined by averaging a 7.0 Å resolution electron-density map, phased by single isomorphous replacement (SIR), about the non-crystallographic threefold-symmetry axis. Iterative non-crystallographic symmetry averaging in real space, solvent flattening and histogram matching were used to extend the phases to 3.5 Å resolution. Molecular replacement of the model into a second crystal form (form II; P43212, a = b = 217.4, c = 421.4 Å) containing two HEF trimers per asymmetric unit permitted iterative ninefold averaging of the electron density. The 3.5 Å electron-density map allowed an unambiguous tracing of the polypeptide chain and identification of N-linked carbohydrates. The model has been refined by least squares to 3.2 Å resolution (R(free) = 26.7%).
UR - http://www.scopus.com/inward/record.url?scp=0033134933&partnerID=8YFLogxK
U2 - 10.1107/S0907444999000232
DO - 10.1107/S0907444999000232
M3 - Article
C2 - 10216291
AN - SCOPUS:0033134933
SN - 0907-4449
VL - 55
SP - 945
EP - 961
JO - Acta Crystallographica Section D: Biological Crystallography
JF - Acta Crystallographica Section D: Biological Crystallography
IS - 5
ER -